Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Gross

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Clinical Trials (London, England)|August 21, 2020
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trialBrett L Houston, Patrick R Lawler, Ewan C Goligher, et al.
The American Journal of Cardiology|July 2, 2017
Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation: From the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) and Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation (CONNECT AF)Alexandra Silberberg, Mary K Tan, Andrew T Yan, et al.
Thrombosis and Haemostasis|December 7, 2017
The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and RationaleJames D Douketis, Alex C Spyropoulos, Julia M Anderson, et al.
Thrombosis and Haemostasis|September 15, 2018
Erratum to: The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant who Need an Elective Surgery or Procedure: Design and RationaleJames D Douketis, Alex C Spyropoulos, Julia M Anderson, et al.
JAMA Internal Medicine|August 6, 2019
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral AnticoagulantJames D Douketis, Alex C Spyropoulos, Joanne Duncan, et al.
The New England Journal of Medicine|April 1, 2022
Tranexamic Acid in Patients Undergoing Noncardiac SurgeryP J Devereaux, Maura Marcucci, Thomas W Painter, et al.
Trials|February 1, 2022
Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgeryMaura Marcucci, Thomas W Painter, David Conen, et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19, , , et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19, , , et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Clinical Trials (London, England)|August 21, 2020
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trialBrett L Houston, Patrick R Lawler, Ewan C Goligher, et al.
The American Journal of Cardiology|July 2, 2017
Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation: From the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) and Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation (CONNECT AF)Alexandra Silberberg, Mary K Tan, Andrew T Yan, et al.
Thrombosis and Haemostasis|December 7, 2017
The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and RationaleJames D Douketis, Alex C Spyropoulos, Julia M Anderson, et al.
Thrombosis and Haemostasis|September 15, 2018
Erratum to: The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant who Need an Elective Surgery or Procedure: Design and RationaleJames D Douketis, Alex C Spyropoulos, Julia M Anderson, et al.
JAMA Internal Medicine|August 6, 2019
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral AnticoagulantJames D Douketis, Alex C Spyropoulos, Joanne Duncan, et al.
The New England Journal of Medicine|April 1, 2022
Tranexamic Acid in Patients Undergoing Noncardiac SurgeryP J Devereaux, Maura Marcucci, Thomas W Painter, et al.
Trials|February 1, 2022
Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgeryMaura Marcucci, Thomas W Painter, David Conen, et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19, , , et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19, , , et al.
Pageof 8